Chris Freeman - Chief Commercial Officer at Guardant Health, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
GH on Nasdaq
All Insider Reports
All Insider Reports

Chris Freeman - trading volume in the past year for Guardant Health, Inc.

Holdings reported by Chris Freeman for Guardant Health, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 43,870 $4,480,881 $102.14 01 Jan 2026 Direct
Performance-Based Restricted Stock Units 5,688 $534,444 $46.98 01 Jan 2026 Direct Common Stock
Restricted Stock Units 17,684 $424,870 $42.47 01 Jan 2026 Direct Common Stock
Stock Option (Right to Buy) 23,145 12 Mar 2025 Direct Common Stock

Transactions reported by Chris Freeman for Guardant Health, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.